Azar, Pouya http://orcid.org/0009-0009-8054-6911
Schneiderman, Hannah
Barron, Henry
Wong, James S. H.
Meyer, Maximilian
Newman-Azar, Dayyon
Narimani, Matin
Ignaszewski, Martha J.
Mathew, Nickie
Mullen, Rodney
Krausz, Reinhard M.
Maharaj, Anil R.
Article History
Received: 15 January 2024
Accepted: 28 May 2024
First Online: 18 June 2024
Declarations
:
: Ethics approval was waived as a case series of fewer than three patients are not subjected to review by our ethics board. Both patients provided written informed consent.
: Not applicable.
: Dr. Pouya Azar is a consultant on Indivior-led buprenorphine extended-release studies, which are unrelated to this case report. All other authors report no conflicts of interest.